1,4-DMAA

1,4-Dimethylamylamine (1,4-DMAA) is a synthetic aliphatic amine stimulant and a positional isomer of the better-known 1,3-dimethylamylamine (1,3-DMAA), differing only in the placement of a methyl group along the carbon chain. It belongs to the same family of simple branched alkylamines that act as central nervous system stimulants without the aromatic ring of the amphetamines. Unlike 1,3-DMAA, it has essentially no history of pharmaceutical development and has never been approved for human consumption, so its pharmacology and safety profile in people remain largely uncharacterized ^[1].

1,4-DMAA came to attention as a designer replacement ingredient after regulators moved against 1,3-DMAA. Analytical investigations of sports and weight-loss supplements sold in the United States identified 1,4-DMAA alongside other experimental stimulants such as octodrine and 1,3-dimethylbutylamine, sometimes stacked together in the same product ^[1][2]. In these surveys the compound was quantified across a wide range of amounts per serving, and in some cases it was present but not declared on the label ^[1][2][4]. It has also been detected as an undeclared adulterant in products marketed under novel botanical names ^[4].

Chemically, 1,4-DMAA is difficult to distinguish from related isomers such as 2-aminoheptane and methylhexaneamine, and specialized techniques including high-resolution gas chromatography with soft ionization and tandem mass spectrometry have been developed to separate and confirm it ^[5]. One analytical study reported detection of both 1,3-DMAA and 1,4-DMAA in geranium (Pelargonium graveolens) plant tissue at nanogram-per-gram concentrations, though the natural occurrence of these amines remains contested ^[3]. Regulators treat 1,4-DMAA as a prohibited, unapproved stimulant, and it is banned in competitive sport; it exists today almost exclusively as an underground supplement ingredient and an analyte of interest in toxicology and anti-doping laboratories ^[2][4].

1,4-DMAA is a structural isomer of DMAA sold as a stimulant, but it has essentially no published human pharmacology or safety data; it is sold as a research chemical, so considerations are inferred from the sympathomimetic amine class. On that basis, plausible effects include elevated blood pressure, tachycardia, arrhythmia and cardiovascular strain, and the complete absence of study data means unrecognized hazards cannot be excluded.

1,4-DMAA is an aliphatic amine sympathomimetic sold in some supplements, and specific human interaction studies are lacking; the relevant basis is the established pharmacology of indirect-acting sympathomimetic amines. Combining such amines with monoamine oxidase inhibitors is a recognized cause of hypertensive crisis, and this contraindication is generally extended to DMAA-type compounds. Additive cardiovascular stimulation with caffeine and other stimulants is a plausible concern that remains theoretical for this specific isomer, and regulators have flagged serious cardiovascular events (hypertension, arrhythmia) associated with DMAA-containing products. No characterized cytochrome P450 interaction data exist for 1,4-DMAA. This is research information, not medical advice.

Checking a whole stack? Run it through interactions + stacks.

The DMAA family traces back to 1,3-DMAA (methylhexanamine), a compound patented by Eli Lilly in the mid-1940s and marketed for a time as an inhaled nasal decongestant before it resurfaced decades later in pre-workout and weight-loss products. 1,4-DMAA is a positional isomer that appeared much more recently, promoted as a next-generation successor once 1,3-DMAA was banned or restricted in numerous countries. Unlike its better-known relative, 1,4-DMAA has no documented record of formal synthesis, discovery, or pharmacological development; it exists almost entirely as an ingredient identified during analyses of adulterated supplements. Its properties are inferred from its chemistry and from the well-studied 1,3-DMAA isomer rather than from any dedicated study of the molecule itself.

1,4-DMAA holds a niche, almost cult reputation among enthusiasts who remember the intense, focused energy of the original DMAA era and seek to recreate it. It is talked about in hardcore pre-workout circles as a rare, hard-hitting stimulant, and that scarcity is a large part of its appeal. Honesty demands a clear caveat, however; because the isomer has never been studied in people, its potency, safety margin, and cardiovascular effects remain genuinely unknown, and it is frequently combined with other experimental stimulants in real-world products. Reviewers who value it still tend to frame it as an experimental ingredient for the informed and cautious rather than an everyday choice.